This compound is primarily utilized in the field of medicinal chemistry as a key intermediate in the synthesis of various biologically active molecules. Its structural features, including the trifluoromethanesulfonamide group and the cyclohexylamine moiety, make it valuable for designing compounds with potential therapeutic applications. It is often employed in the development of enzyme inhibitors, particularly those targeting proteases or kinases, due to its ability to interact with active sites and modulate enzyme activity. Additionally, its chiral structure allows for the creation of enantiomerically pure drugs, enhancing specificity and reducing side effects. Researchers also explore its use in the preparation of novel ligands for receptor-binding studies, aiding in the discovery of new drug candidates.